Granulocyte-colony stimulating factor improves outcome in a mouse model of amyotrophic lateral sclerosis

Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease that results in progressive loss of motoneurons, motor weakness and death within 1–5 years after disease onset. Therapeutic options remain limited despite a substantial number of approaches that have been tested clinicall...

Descripción completa

Detalles Bibliográficos
Autores principales: Pitzer, Claudia, Krüger, Carola, Plaas, Christian, Kirsch, Friederike, Dittgen, Tanjew, Müller, Ralph, Laage, Rico, Kastner, Stefan, Suess, Stefanie, Spoelgen, Robert, Henriques, Alexandre, Ehrenreich, Hannelore, Schäbitz, Wolf-Rüdiger, Bach, Alfred, Schneider, Armin
Formato: Texto
Lenguaje:English
Publicado: Oxford University Press 2008
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2639207/
https://www.ncbi.nlm.nih.gov/pubmed/18835867
http://dx.doi.org/10.1093/brain/awn243

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2639207/
https://www.ncbi.nlm.nih.gov/pubmed/18835867
http://dx.doi.org/10.1093/brain/awn243

Ejemplares similares